Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · IEX Real-Time Price · USD
12.93
+0.23 (1.81%)
Apr 26, 2024, 1:02 PM EDT - Market open
Viridian Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for VRDN stock have an average target of 37.8, with a low estimate of 25 and a high estimate of 51. The average target predicts an increase of 192.34% from the current stock price of 12.93.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 21, 2024.
Analyst Ratings
The average analyst rating for VRDN stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 6 | 6 | 6 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $29 → $25 | Strong Buy | Maintains | $29 → $25 | +93.35% | Mar 21, 2024 |
| Needham | Needham | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +132.02% | Mar 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +186.16% | Feb 29, 2024 |
| Wedbush | Wedbush | Buy Maintains $39 → $40 | Buy | Maintains | $39 → $40 | +209.36% | Feb 28, 2024 |
| Needham | Needham | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +132.02% | Feb 28, 2024 |
Financial Forecast
Revenue This Year
273.18K
from 314.00K
Decreased by -13.00%
Revenue Next Year
7.38M
from 273.18K
Increased by 2,600.45%
EPS This Year
-4.64
from -5.31
EPS Next Year
-4.67
from -4.64
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.1M | 42.7M | 709.8M | 1.5B | 1.9B |
| Avg | 273,176 | 7.4M | 164.3M | 562.4M | 998.8M |
| Low | n/a | n/a | 25.3M | 168.6M | 314.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 568.8% | 15,543.7% | 9,522.3% | 810.9% | 231.5% |
| Avg | -13.0% | 2,600.5% | 2,127.7% | 242.2% | 77.6% |
| Low | - | - | 242.9% | 2.6% | -44.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.61 | -3.39 | 4.08 | 7.43 | 8.57 |
| Avg | -4.64 | -4.67 | -2.40 | 0.43 | 3.90 |
| Low | -5.61 | -6.56 | -3.81 | -3.22 | -0.58 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 1,893.4% |
| Avg | - | - | - | - | 808.5% |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.